Coronary Artery Disease Clinical Trial
Official title:
Robot Assisted Percutaneous Cardiovascular Intervention as a Strategy to Reduce or Risk of Intra-Procedure Contamination by COVID-19 and Other Respiratory Viruses
Percutaneous cardiovascular intervention procedures (e.g. coronary angioplasty, peripheral
artery angioplasty) must be performed in person, requiring the physical presence of one or
more medical, nursing and technical professionals. The control of catheters and
interventional materials is performed manually, with the operator positioned next to the
patient. This context results in potential for reciprocal exposure to exhaled air, both for
the professionals involved and for the patient, with an inherent risk of aerial
contamination. It is important to note that interventional procedures are often performed on
an urgent or emergency basis (e.g. myocardial infarction), without the possibility of
postponement or postponement.
The recent robot-assisted cardiovascular intervention makes it possible to modify this
scenario by allowing the procedure to be performed effectively and safely in a position far
from the patient. In an environment with high potential for contamination, mainly related to
the current pandemic caused by the COVID-19 virus, may prove to be a tactic to expand
hospital security.
It is in this sense that the present pilot proposal is inserted, which, ultimately, aims to
evaluate the potential of robotic intervention as a strategy to reduce exposure to exhaled
air of patients and professionals during the intervention procedure.
Percutaneous cardiovascular intervention procedures (e.g. coronary angioplasty, peripheral
artery angioplasty) must be performed in person, requiring the physical presence of one or
more medical, nursing and technical professionals. The control of catheters and
interventional materials is performed manually, with the operator positioned next to the
patient. This context results in potential for reciprocal exposure to exhaled air, both for
the professionals involved and for the patient, with an inherent risk of aerial
contamination. It is important to note that interventional procedures are often performed on
an urgent or emergency basis (e.g. myocardial infarction), without the possibility of
postponement or postponement.
The recent robot-assisted cardiovascular intervention makes it possible to modify this
scenario by allowing the procedure to be performed effectively and safely in a position far
from the patient. In an environment with high potential for contamination, mainly related to
the current pandemic caused by the COVID-19 virus, may prove to be a tactic to expand
hospital security.
It is in this sense that the present pilot proposal is inserted, which, ultimately, aims to
evaluate the potential of robotic intervention as a strategy to reduce exposure to exhaled
air of patients and professionals during the intervention procedure.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06030596 -
SPECT Myocardial Blood Flow Quantification for Diagnosis of Ischemic Heart Disease Determined by Fraction Flow Reserve
|
||
| Completed |
NCT04080700 -
Korean Prospective Registry for Evaluating the Safety and Efficacy of Distal Radial Approach (KODRA)
|
||
| Recruiting |
NCT03810599 -
Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study
|
N/A | |
| Recruiting |
NCT06002932 -
Comparison of PROVISIONal 1-stent Strategy With DEB Versus Planned 2-stent Strategy in Coronary Bifurcation Lesions.
|
N/A | |
| Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
| Recruiting |
NCT05308719 -
Nasal Oxygen Therapy After Cardiac Surgery
|
N/A | |
| Recruiting |
NCT04242134 -
Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions
|
N/A | |
| Completed |
NCT04556994 -
Phase 1 Cardiac Rehabilitation With and Without Lower Limb Paddling Effects in Post CABG Patients.
|
N/A | |
| Recruiting |
NCT05846893 -
Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease
|
N/A | |
| Recruiting |
NCT06027788 -
CTSN Embolic Protection Trial
|
N/A | |
| Recruiting |
NCT05023629 -
STunning After Balloon Occlusion
|
N/A | |
| Completed |
NCT04941560 -
Assessing the Association Between Multi-dimension Facial Characteristics and Coronary Artery Diseases
|
||
| Completed |
NCT04006288 -
Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease
|
Phase 4 | |
| Completed |
NCT01860274 -
Meshed Vein Graft Patency Trial - VEST
|
N/A | |
| Recruiting |
NCT06174090 -
The Effect of Video Education on Pain, Anxiety and Knowledge Levels of Coronary Bypass Graft Surgery Patients
|
N/A | |
| Completed |
NCT03968809 -
Role of Cardioflux in Predicting Coronary Artery Disease (CAD) Outcomes
|
||
| Terminated |
NCT03959072 -
Cardiac Cath Lab Staff Radiation Exposure
|
||
| Recruiting |
NCT04566497 -
Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up.
|
N/A | |
| Recruiting |
NCT05065073 -
Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography
|
Phase 4 | |
| Completed |
NCT05096442 -
Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions
|
N/A |